{
    "eid": "2-s2.0-85055149780",
    "title": "Optimizing Clinical Trial Design to Maximize Evidence Generation in Pediatric HIV",
    "cover-date": "2018-08-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology (medical)",
            "@code": "2736",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Clinical trial design",
        "Pediatric clinical trials",
        "Pediatric HIV"
    ],
    "authors": [
        "Deborah Ford",
        "Rebecca Turner",
        "Anna Turkova",
        "Martina Penazzato",
        "Victor Musiime",
        "Mutsa Bwakura-Dangarembizi",
        "Avy Violari",
        "Chishala Chabala",
        "Thanyawee Puthanakit",
        "Tavitiya Sudjaritruk",
        "Tim R. Cressey",
        "Marc Lallemant",
        "Diana M. Gibb"
    ],
    "citedby-count": 7,
    "ref-count": 62,
    "ref-list": [
        "Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis",
        "Predicting patterns of long-term CD4 reconstitution in HIV-infected children starting antiretroviral therapy in sub-Saharan Africa: a cohort-based modelling study",
        "Extrapolation of adult data and other data in pediatric drug-development programs",
        "Developmental pharmacology\u2013drug disposition, action, and therapy in infants and children",
        "Paediatric Antiretroviral Working Group. Prioritizing the most needed formulations to accelerate paediatric antiretroviral therapy scale-up",
        "Antiretroviral drugs in pediatric HIV-infected patients: pharmacokinetic and practical challenges",
        "Optimizing research to speed up availability of pediatric antiretroviral drugs and formulations",
        "Setting priorities in global child health research investments: guidelines for implementation of CHNRI method",
        "Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial",
        "Early versus deferred antiretroviral therapy for children older than 1 year infected with HIV (PREDICT): a multicentre, randomised, open-label trial",
        "More multiarm randomised trials of superiority are needed",
        "Multiplicity considerations in the design and analysis of clinical trials",
        "Multiplicity in randomised trials I: endpoints and treatments",
        "Early antiretroviral therapy and mortality among HIV-infected infants",
        "Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial",
        "Abacavir, zidovudine, or stavudine as paediatric tablets for African HIV-infected children (CHAPAS-3): an open-label, parallel-group, randomised controlled trial",
        "Routine versus clinically driven laboratory monitoring and first-line antiretroviral therapy strategies in African children with HIV (ARROW): a 5-year open-label randomised factorial trial",
        "Design, analysis and presentation of factorial randomised controlled trials",
        "First-line antiretroviral therapy with a protease inhibitor versus nonnucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial",
        "Mortality in the year following antiretroviral therapy initiation in HIV-infected adults and children in Uganda and Zimbabwe",
        "Enhanced prophylaxis plus antiretroviral therapy for advanced HIV infection in Africa",
        "Once vs twice-daily abacavir and lamivudine in African children",
        "A randomized trial of prolonged co-trimoxazole in HIV-infected children in Africa",
        "Testing many treatments within a single protocol over 10 years at MRC Clinical Trials Unit at UCL: multi-arm, multi-stage platform, umbrella and basket protocols",
        "Antiretroviral treatment for children with peripartum nevirapine exposure",
        "Nevirapine versus ritonavir-boosted lopinavir for HIV-infected children",
        "Nevirapine- versus lopinavir/ritonavir-based antiretroviral therapy in HIV-infected infants and young children: long-term follow-up of the IMPAACT P1060 randomized trial",
        "Adaptive trial designs: a review of barriers and opportunities",
        "The role of adaptive trial designs in drug development",
        "Speeding up the evaluation of new agents in cancer",
        "The pharmacokinetics and acceptability of lopinavir/ritonavir minitab sprinkles, tablets, and syrups in African HIV-infected children",
        "Acceptability of lopinavir/r pellets (minitabs), tablets and syrups in HIV-infected children",
        "Contamination in trials: is cluster randomisation the answer?",
        "Evidence for risk of bias in cluster randomised trials: review of recent trials published in three general medical journals",
        "Cluster randomized trial on the effect of mother support groups on retention-in-care and PMTCT outcomes in Zimbabwe: study design, challenges, and national relevance",
        "Goodstart: a cluster randomised effectiveness trial of an integrated, community-based package for maternal and newborn care, with prevention of mother-to-child transmission of HIV in a South African township",
        "Evaluating a multi-component, community-based program to improve adherence and retention in care among adolescents living with HIV in Zimbabwe: study protocol for a cluster randomized controlled trial",
        "Excellence TNo. Innovative study design for paediatric clinical trials",
        "A framework for applying unfamiliar trial designs in studies of rare diseases",
        "Experimental designs for small randomised clinical trials: an algorithm for choice",
        "Randomized noninferiority trial of two maternal single-dose nevirapine-sparing regimens to prevent perinatal HIV in Thailand",
        "Antiretroviral intensification to prevent intrapartum HIV transmission in late comers",
        "Contribution of different antiretroviral regimens containing zidovudine, lamivudine and ritonavir-boosted lopinavir on HIV viral load reduction during pregnancy",
        "Modeling of in-utero and intrapartum transmissions to evaluate the efficacy of interventions for the prevention of perinatal HIV",
        "A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators",
        "Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand",
        "Bayesian approach to randomized controlled trials in children utilizing information from adults: the case of Guillain-Barre syndrome",
        "Bayesian design using adult data to augment pediatric trials",
        "Enhancing pediatric clinical trial feasibility through the use of Bayesian statistics",
        "Effect of grass sublingual tablet immunotherapy is similar in children and adults: a Bayesian approach to design pediatric sublingual immunotherapy trials",
        "Hepatitis B in sub-Saharan Africa: strategies to achieve the 2030 elimination targets"
    ],
    "affiliation": [
        {
            "affiliation-city": "Chaing Mai",
            "@id": "60000881",
            "affilname": "Chiang Mai University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000881",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Lusaka",
            "@id": "60072805",
            "affilname": "University Teaching Hospital Lusaka",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60072805",
            "affiliation-country": "Zambia"
        },
        {
            "affiliation-city": "Lusaka",
            "@id": "60072796",
            "affilname": "University of Zambia",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60072796",
            "affiliation-country": "Zambia"
        },
        {
            "affiliation-city": "Kampala",
            "@id": "60071691",
            "affilname": "Joint Clinical Research Center Uganda",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60071691",
            "affiliation-country": "Uganda"
        },
        {
            "affiliation-city": "Kampala",
            "@id": "60071676",
            "affilname": "Makerere University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60071676",
            "affiliation-country": "Uganda"
        },
        {
            "affiliation-city": "Harare",
            "@id": "60033774",
            "affilname": "University of Zimbabwe",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60033774",
            "affiliation-country": "Zimbabwe"
        },
        {
            "affiliation-city": "Boston",
            "@id": "60032499",
            "affilname": "Harvard T.H. Chan School of Public Health",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60032499",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Chaing Mai",
            "@id": "60032250",
            "affilname": "Faculty of Medicine, Chiang Mai University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60032250",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Geneva",
            "@id": "60027142",
            "affilname": "Organisation Mondiale de la Sant\u00e9",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60027142",
            "affiliation-country": "Switzerland"
        },
        {
            "affiliation-city": "London",
            "@id": "60022148",
            "affilname": "University College London",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022148",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "Liverpool",
            "@id": "60020661",
            "affilname": "University of Liverpool",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60020661",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "Johannesburg",
            "@id": "60016218",
            "affilname": "University of the Witwatersrand, Johannesburg",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016218",
            "affiliation-country": "South Africa"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Medical Research Council"
    ]
}